BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11418005)

  • 41. Role of physical factors in the regulation of mesangial cell growth and the interaction with vasoactive agents.
    Harris RC; Akai Y; Yasuda T; Homma T
    Exp Nephrol; 1994; 2(2):104. PubMed ID: 8082000
    [No Abstract]   [Full Text] [Related]  

  • 42. Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling.
    Doan TN; Ali MS; Bernstein KE
    J Biol Chem; 2001 Jun; 276(24):20954-8. PubMed ID: 11319216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-1 inhibits angiotensin II-stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase.
    Rölz W; Xin C; Ren S; Pfeilschifter J; Huwiler A
    Eur J Pharmacol; 2002 May; 442(3):195-203. PubMed ID: 12065072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the STAT pathway by angiotensin II in T3CHO/AT1A cells. Cross-talk between angiotensin II and interleukin-6 nuclear signaling.
    Bhat GJ; Thekkumkara TJ; Thomas WG; Conrad KM; Baker KM
    J Biol Chem; 1995 Aug; 270(32):19059-65. PubMed ID: 7642569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Importance of Tyrosine Phosphorylation in Angiotensin II Signaling.
    Bernstein KE; Marrero MB
    Trends Cardiovasc Med; 1996 Aug; 6(6):179-87. PubMed ID: 21232294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice.
    Lorenzo Ó; Ruiz-Ortega M; Suzuki Y; Rupérez M; Esteban V; Sugaya T; Egido J
    J Am Soc Nephrol; 2002 May; 13(5):1162-1171. PubMed ID: 11961003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype.
    Huwiler A; van Rossum G; Wartmann M; Pfeilschifter J
    Eur J Pharmacol; 1998 Feb; 343(2-3):297-302. PubMed ID: 9570479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the JAK2/STAT pathway and losartan in human glomerular mesangial cell senescence.
    Zhou H; Huang B; Du J; Wang L
    Mol Med Rep; 2010; 3(3):393-8. PubMed ID: 21472252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension.
    AbdAlla S; Abdel-Baset A; Lother H; el Massiery A; Quitterer U
    J Mol Neurosci; 2005; 26(2-3):185-92. PubMed ID: 16012192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells.
    Johnson LR; McCormack SA; Yang CH; Pfeffer SR; Pfeffer LM
    Am J Physiol; 1999 Feb; 276(2):C419-25. PubMed ID: 9950769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin II stimulation of phospholipase D in rat renal mesangial cells is mediated by the AT1 receptor subtype.
    Pfeilschifter J; Huwiler A; Merriweather C; Briner VA
    Eur J Pharmacol; 1992 Jan; 225(1):57-62. PubMed ID: 1541325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening and identification of the up-regulated genes in human mesangial cells exposed to angiotensin II.
    Liang X; Zhang H; Zhou A; Hou P; Wang H
    Hypertens Res; 2003 Mar; 26(3):225-35. PubMed ID: 12675278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.
    Moriyama T; Fujibayashi M; Fujiwara Y; Kaneko T; Xia C; Imai E; Kamada T; Ando A; Ueda N
    J Am Soc Nephrol; 1995 Jul; 6(1):95-101. PubMed ID: 7579076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II maintains the structure and function of glomerular mesangium via type 1a receptor. What we have learned from null mutant mice minus the angiotensin II type 1a receptor gene.
    Inokuchi S; Kimura K; Sugaya T; Yoneda H; Shirato I; Murakami K; Sakai T
    Virchows Arch; 1998 Oct; 433(4):349-57. PubMed ID: 9808437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.
    Mascareno E; Dhar M; Siddiqui MA
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5590-4. PubMed ID: 9576927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design of conditionally active STATs: insights into STAT activation and gene regulatory function.
    Milocco LH; Haslam JA; Rosen J; Seidel HM
    Mol Cell Biol; 1999 Apr; 19(4):2913-20. PubMed ID: 10082558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino-terminal signal transducer and activator of transcription (STAT) domains regulate nuclear translocation and STAT deactivation.
    Strehlow I; Schindler C
    J Biol Chem; 1998 Oct; 273(43):28049-56. PubMed ID: 9774421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components.
    Ulane CM; Horvath CM
    Virology; 2002 Dec; 304(2):160-6. PubMed ID: 12504558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Stat 5B as a substrate of the insulin receptor.
    Sawka-Verhelle D; Filloux C; Tartare-Deckert S; Mothe I; Van Obberghen E
    Eur J Biochem; 1997 Dec; 250(2):411-7. PubMed ID: 9428692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac effects of AII. AT1A receptor signaling, desensitization, and internalization.
    Thomas WG; Thekkumkara TJ; Baker KM
    Adv Exp Med Biol; 1996; 396():59-69. PubMed ID: 8726686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.